In contrast, CD84 is present in a significant proportion of highly immunosuppressive M-MDSCs in the blood of cancer patients (between 60 and 95%) [19, 20], which is consistent with our observations in MS white matter lesions. This evidence concerns the gene CD84 and myeloid sarcoma.